Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 3/20 | 0.54 |
| ▸ | CA1 | P00915 | 3/20 | 0.50 |
| ▸ | CA2 | P00918 | 3/20 | 0.50 |
| ▸ | CA12 | O43570 | 1/20 | 0.50 |
| ▸ | CA3 | P07451 | 1/20 | 0.50 |
| ▸ | CA6 | P23280 | 1/20 | 0.50 |
| ▸ | CA5A | P35218 | 1/20 | 0.50 |
| ▸ | CA7 | P43166 | 1/20 | 0.50 |
| ▸ | CA9 | Q16790 | 1/20 | 0.50 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.50 |
| ▸ | TLR9 | Q9NR96 | 1/20 | 0.48 |
| ▸ | VDR | P11473 | 1/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.45 |
| ▸ | MMP1 | P03956 | 1/20 | 0.45 |
| ▸ | MMP2 | P08253 | 1/20 | 0.45 |
| ▸ | MMP9 | P14780 | 1/20 | 0.45 |
| ▸ | MMP8 | P22894 | 1/20 | 0.45 |
| ▸ | MMP13 | P45452 | 1/20 | 0.45 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30027753 | 0.82 | GAA (0.50) | GAACA1CA2CA12CA3 | |
| SCHEMBL6490 | 0.80 | GAA (0.59) | GAACA1CA2CA12CA3 | |
| SCHEMBL7186972 | 0.80 | GAA (0.59) | GAACA1CA2CA12CA3 | |
| Iodomethane SCHEMBL28262975 | 0.79 | GAA (0.52) | GAACA1CA2CA12CA3 | |
| Water SCHEMBL3352692 | 0.78 | GAA (0.56) | GAACA1CA2CA12CA3 | |
| SCHEMBL15256448 | 0.78 | GAA (0.56) | GAACA1CA2CA12CA3 | |
| SCHEMBL9901122 | 0.78 | GAA (0.56) | GAACA1CA2CA12CA3 | |
| SCHEMBL30862469 | 0.78 | GAA (0.56) | GAACA1CA2CA12CA3 | |
| SCHEMBL27524 | 0.78 | GAA (0.56) | GAACA1CA2CA12CA3 | |
| SCHEMBL17256433 | 0.77 | GAA (0.50) | GAACA1CA2CA12CA3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 251 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4319788-A1 | REGULATION OF CELLS AND ORGANISMS | Tets, Victor (US) | 2024-02-14 | — | — | EP | claimed |
| WO-2023082272-A1 | UPLINK SYNCHRONIZATION METHOD AND APPARATUS, AND READABLE STORAGE MEDIUM | 北京小米移动软件有限公司 | 2023-05-19 | — | — | WO | claimed |
| CN-115730848-A | Decision processing method, device and computer readable storage medium | 北京大学 | 2023-03-03 | — | — | CN | claimed |
| WO-2022214966-A1 | REGULATION OF CELLS AND ORGANISMS | TETS VICTOR (US) | 2022-10-13 | — | — | WO | claimed |
| CN-114270962-A | Uplink synchronization method and device and readable storage medium | 北京小米移动软件有限公司 | 2022-04-01 | — | — | CN | claimed |
| EP-0618919-B1 | IODINIUM SALTS AND METHOD OF PREPARING THEM | WACKER CHEMIE GMBH (DE) | 1996-02-28 | — | — | EP | claimed |
| US-5468890-A | Iodonium salts and process for the preparation thereof | WACKER-CHEMIE GMBH (DE) | 1995-11-21 | — | — | US | claimed |
| EP-4734589-A1 | COMMUNICATION METHOD, DEVICES, COMMUNICATION DEVICE, COMMUNICATION SYSTEM, AND STORAGE MEDIUM | Beijing Xiaomi Mobile Software Co., Ltd. (CN) | 2026-04-29 | — | — | EP | disclosed |
| EP-4723576-A1 | INFORMATION PREDICTION METHOD AND APPARATUS, NETWORK DEVICE, AND NODE DEVICE | CHINA MOBILE COMMUNICATION CO., LTD RESEARCH INSTITUTE (CN) | 2026-04-08 | — | — | EP | disclosed |
| US-12574825-B2 | Communication method and apparatus, storage medium, and chip system | HUAWEI TECHNOLOGIES CO., LTD. | 2026-03-10 | — | — | US | disclosed |
| EP-3961718-B1 | DISPLAY DEVICE | SAMSUNG DISPLAY CO LTD (KR) | 2026-03-04 | — | — | EP | disclosed |
| EP-4184410-B1 | OPERATING SYSTEM FOR BLOCKCHAIN IOT DEVICES | NCHAIN LICENSING AG (CH) | 2026-03-04 | — | — | EP | disclosed |
| US-20260050809-A1 | Quantum Enhanced Behavioral Analysis And Secure Database Operation System | Anonemis Research (US) | 2026-02-19 | — | — | US | disclosed |
| US-5672599-A | DUAL ACTION ANGIOTENSIN CONVERTING ENZYME INHIBITORS AND NEUTRAL ENDOPEPTIDASE INHIBITORS; TREATMENT OF CARDIOVASCULAR DISORDERS | BRISTOL-MYERS SQUIBB CO. (US) | 1997-09-30 | — | — | US | disclosed |
| US-5508272-A | SELECTIVE ACE INHIBITORS, HYPOTENSIVE AGENTS | BRISTOL-MYERS SQUIBB COMPANY (US) | 1996-04-16 | — | — | US | disclosed |
| US-5468890-A | Iodonium salts and process for the preparation thereof | WACKER-CHEMIE GMBH (DE) | 1995-11-21 | — | — | US | disclosed |
| US-5144051-A | Improved solubility; photinitiators for epoxy compounds or expoxysilanes | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1992-09-01 | — | — | US | disclosed |
| US-5086192-A | Photopolymerizable compositions and photoinitiators therefor | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1992-02-04 | — | — | US | disclosed |
| US-4780511-A | Method for making polymeric photoactive aryl iodonium salts, products obtained therefrom, and use | GENERAL ELECTRIC COMPANY (US) | 1988-10-25 | — | — | US | disclosed |
| US-4748272-A | Phenoxyphenylacetates for use as potential modulators of arichidonic acid pathways | RORER PHARMACEUTICAL CORP. (US) | 1988-05-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12574825-B2 | Communication method and apparatus, storage medium, and chip system | SLIRP, STAT1, STUB1 | GAA 4861/4885CA1 4728/4885CA2 4880/4885 |
| US-20260050809-A1 | Quantum Enhanced Behavioral Analysis And Secure Database Operation System | DCX, NCS1, SNCA | GAA 2161/4885CA1 734/4885CA2 1724/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.